Anda di halaman 1dari 2

DAFTAR PUSTAKA

American Pharmacists Association. 2009. Drug Information Handbook 17th


Edition. USA: Lexi-Comp Inc.
ASEAN. 2013. ASEAN Guideline On Stability Study Of Drug Product. Available
online at http://www.hsa.gov.sg/content/dam/HSA/HPRG/Western_Medicine
/Overview_Framework_Policies/Guidelines_on_Drug_Registration/ASEAN
%20STABILITY%20GUIDELINE%20(version%206.0).pdf/. [Diakses pada
tanggal 5 Januari 2016].
Badan Pengawas Obat dan Makanan RI. 1971. Keputusan Menteri Kesehatan RI
No.193/Kab/B.VII/71 tentang Pembungkusan dan Penandaan Obat. Jakarta:
BPOM RI.
Badan Pengawas Obat dan Makanan RI. 1977. Keputusan Menteri Kesehatan RI
No.197/A/SK/77 tentang Pembungkusan dan Penandaan Obat Keras.
Jakarta: BPOM RI.
Badan Pengawas Obat dan Makanan RI. 1986. Keputusan Menteri Kesehatan RI
No.02396/A/SK/VIII/86 tentang Tanda Khusus Obat Keras Daftar G.
Jakarta: BPOM RI.
Badan Pengawas Obat dan Makanan RI. 2006. Petunjuk Operasional Penerapan
Cara Pembuatan Obat yang Baik Edisi 2006. Jakarta: BPOM RI.
Badan Pengawas Obat dan Makanan RI. 2008. Peraturan Menteri Kesehatan
Republik Indonesia Nomor 1010/Menkes/Per/XI/2008 tentang Registrasi
Obat. Jakarta: BPOM RI.
Badan Pengawas Obat dan Makanan RI. 2011. Peraturan Kepala Badan
Pengawas
Obat
dan
Makanan
Republik
Indonesia
No.
HK.03.1.23.10.11.08481 tahun 2011 tentang Kriteria dan Tata Laksana
Registrasi Obat. Jakarta: BPOM RI.
Badan Pengawas Obat dan Makanan RI. 2012. Pedoman Cara Pembuatan Obat
yang Baik. Jakarta: BPOM RI.
Badan Pengawas Obat dan Makanan RI. 2012. Cefixime. Available online at
http://www.ceknie.pom.go.id/index.php/home/produk/2f911e3de66a6c08f62
e78a5764fd6be/all/row/10/page/1/order/4/DESC/search/5/cefixime/.
[Diakses pada tanggal 5 Januari 2016].
Baxter, K. 2009. Stockleys Drug Interactions: A Source Book of Interactions,
Their Mechanisms, Clinical Importance and Management 9 th Edition.
Florida: CRC Press.
British Pharmacopoeia Commission. 2009. British Pharmacopoeia 2009. London:
The Stationery Office.
45

British Pharmacopoeia Commission. 2013. British Pharmacopoeia 2013. London:


The Stationery Office.
Departemen Kesehatan RI. 1995. Farmakope Indonesia Edisi IV. Jakarta:
Departemen Kesehatan RI.
Departemen Kesehatan RI. 2014. Farmakope Indonesia Edisi V. Jakarta:
Departemen Kesehatan RI.
Florey, K. and B. G. Harry. 2005. Analytical Profiles of Drug Substances and
Excipients Volume 25. London: Academic Press.
International Conference Of Harmonization. 1996. Stability Testing:
Photostability Testing Of New Drug Substances And Products Q1B.
Available
online
at
http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinform
ation/guidances/ucm073373.pdf/. [Diakses pada tanggal 5 Januari 2016].
International Conference Of Harmonization. 2006. Stability Testing Of New Drug
Substances And Products Q1A (R2). Available online at
http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinform
ation/guidances/ucm073369.pdf/. [Diakses pada tanggal 5 Januari 2016].
Katzung, G. B. 2012. Basic and Clinical Pharmacology 12th Edition. New York:
McGrawHill.
Lieberman H. A., M. M. Reiger, and G. S. Banker. 1989. Pharmaceutical Dosage
Forms: Disperse Systems Volume 2. New York: Marcel Dekker.
Niazi, S. 2004. Handbook of Pharmaceutical Manufacturing: Uncompressed
Solid Products 2nd Edition. New York: Taylor & Francis.
Rowe, R. C., P. J. Sheckey, and M. E. Quinn. 2009. Handbook of Pharmaceutical
Excipients 6th Edition. London: Pharmaceutical Press.
Srinivasu, Rao BN3, Mathrusri A, Ashutosh S1 and ChandrashekharT. 2012.
Development and Validation of High Performance Liquid Chromatography
Method for Quantification of Related Substances in Clarithromycin Powder
for An Oral Suspension Dosage Form. Journal International Analytical,
Pharmaceutical and Biomedical Science.
Sweetman, Sean C. 2009. Martindale The Complete Drug Reference 36th Edition.
London: Pharmaceutical Press.
The United States Pharmacopeia Convention. 2012. United States Pharmacopeia
35 National Formulary 30. USA: The United States Pharmacopeia
Convention.
World Health Organization. 2009. Annex 2: Stability Testing Of Active
Pharmaceutical Ingredients And Fnished Pharmaceutical Products. WHO
Technical Report Series, No. 953.

46